Proposed model for the pathogenic role of the NLRP3 inflammasome signaling pathway in RA and its clinical implications as the therapeutic potential

The proposed model for the pathogenic role of the NLRP3 inflammasome signaling pathway in RA and its clinical implications as the therapeutic potential. Several ligands that bind to TNFRs and TLRs can activate nuclear factor (NF)-κB. As a transcription factor, activated NF-κB can translocate into the nucleus and thereby activate the expression of NLRP3 and pro-IL-1β. As an endogenous ligand, anti-citrullinated peptide antibodies (ACPA) can promote NF-κB phosphorylation through binding to TNFRs and TLRs. In the second signal, extracellular ATP can bind to P2X7 and thereby lead to K+ efflux and extracellular Ca++ influx, which activate the NLRP3 inflammasome with the overproduction of the mature form of IL-1β and IL-18. The NLRP3 inflammasome activation also leads to the cleavage of gasdermin D, which promotes pyroptosis with the formation of pores in the cell membrane and the release of IL-1β and IL-18. ACPA can also activate the pannexin channel, resulting in ATP secretion and NLRP3 inflammation activation. In RA monocytes, complement C1q and pentaxin 3 (PTX3) synergistically activate the NLRP3 inflammasome and pyroptosis. Several compounds have been identified as inhibitors of the components of the NLRP3 inflammasome signaling pathway. MCC950, VX-765, osthole, and sulforaphane can inhibit the activation of the NLRP3 inflammasome. Tofacitinib, one JAKi, may restore the balance of γδTreg/γδT17 cells in RA by inhibiting the NLRP3 inflammasome. Disulfiram inhibits GSDMD and thereby blocks pyroptosis and the release of IL-1β and IL-18. Anakinra, an IL-1β receptor antagonist, blocks the effects of NLRP3 inflammasome downstream cytokine. Among natural products, both Baihu-Guizhi decoction (BHGZD) and celastrol can inhibit NLRP3 activation by blocking the NF-κB pathway. HCQ could inhibit Ca2+-activated K+ channels and then impair inflammasome activation. The microRNA-30a and miR-223 inhibit the expression of NLRP3 and inflammasome activation. Red arrows indicate activation of NLRP3 inflammasome. Block arrows trigger protein expression pathway. RA: rheumatoid arthritis; TNFα: tumor necrosis factor-α; TNFRs: TNFα receptors; TLRs: Toll-like receptors; ATP: adenosine triphosphate; PTX3: pentaxin 3; GSDMD: gasdermin D; IL: interleukin; ASCVD: atherosclerotic cardiovascular disease; OP: osteoporosis; ILD: interstitial lung disease
Proposed model for the pathogenic role of the NLRP3 inflammasome signaling pathway in RA and its clinical implications as the therapeutic potential

Publication

The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review (2024) Po-Ku Chen, et al. Int J Mol Sci. 2024 Jan;25(1). Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates TNFα TNF ncbigene_symbol TNF 7124
Homo sapiens Primates ACPA ACPA ncbigene_synonym PRTN3 5657
Homo sapiens Primates TLRs TLR famplex_relations TLR1 7096
Homo sapiens Primates TLRs TLR famplex_relations TLR2 7097
Homo sapiens Primates TLRs TLR famplex_relations TLR3 7098
Homo sapiens Primates TLRs TLR famplex_relations TLR4 7099
Homo sapiens Primates TLRs TLR famplex_relations TLR5 7100
Homo sapiens Primates TLRs TLR famplex_relations TLR6 10333
Homo sapiens Primates TLRs TLR famplex_relations TLR7 51284
Homo sapiens Primates TLRs TLR famplex_relations TLR8 51311
Homo sapiens Primates TLRs TLR famplex_relations TLR9 54106
Homo sapiens Primates TLRs TLR famplex_relations TLR10 81793
Homo sapiens Primates NLRP3 NLRP3 ncbigene_symbol NLRP3 114548
Homo sapiens Primates ATP ATP ncbigene_synonym ATP8A2 51761
Homo sapiens Primates P2X7 P2X7 ncbigene_synonym P2RX7 5027
Homo sapiens Primates C1q C1Q famplex_relations C1QA 712
Homo sapiens Primates C1q C1Q famplex_relations C1QB 713
Homo sapiens Primates PTX3 PTX3 ncbigene_symbol PTX3 5806
Homo sapiens Primates PTX3 PTX3 ncbigene_synonym PITX3 5309
Homo sapiens Primates NFKB NFKB ncbigene_synonym NFKB1 4790
Homo sapiens Primates NFKB NFKB famplex_relations RELA 5970
Homo sapiens Primates NFKB NFKB famplex_relations RELB 5971
Homo sapiens Primates NFKB NFKB famplex_relations REL 5966
Homo sapiens Primates NFKB NFKB famplex_relations NFKB2 4791
Homo sapiens Primates GSDMD GSDMD ncbigene_symbol GSDMD 79792
Homo sapiens Primates miR-223 MIR-223 ncbigene_synonym MIR223 407008
Homo sapiens Primates IL-1ẞ IL1 ncbigene_synonym IL1A 3552
Homo sapiens Primates IL-1ẞ IL1 ncbigene_synonym IL1B 3553
Homo sapiens Primates IL-18 IL-18 ncbigene_synonym IL18 3606
Homo sapiens Primates Jak JAK famplex_relations JAK1 3716
Homo sapiens Primates Jak JAK famplex_relations JAK2 3717
Homo sapiens Primates Jak JAK famplex_relations JAK3 3718
Homo sapiens Primates Jak JAK famplex_relations TYK2 7297
Homo sapiens Primates MIAT MIAT ncbigene_symbol MIAT 440823
Homo sapiens Primates IL-18BP IL18BP ncbigene_symbol IL18BP 10068

Chemical mentions

Word Match MeSH Name ChEBI
ATP ATP ATP chebi:30616
ATP ATP ATP chebi:30616
Nucleus nucleus nucleus chebi:33252
Tofacitinib tofacitinib 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile chebi:71200

Disease mentions

Word Match MeSH Name DOID